In reversal, US agrees to review new Moderna flu shot
In reversal, US agrees to review new Moderna flu shot is drawing significant interest across the industry.
Vaccine manufacturer Moderna said Wednesday the US Food and Drug Administration walked back its previous position and agreed to review the company's new
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- Verobish committed to sound policies
- Waubonsee increasing tuition rate starting in the fall
- Hundreds rally to keep Alberta Canadian
- Four better love stories to watch than Netflix's Bridgerton
Source: Original →